Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps.
about
Leveraging a Sturge-Weber Gene Discovery: An Agenda for Future Research.Physiologically Based Pharmacokinetic Modeling in Pediatric Oncology Drug Development.Current mathematical models for cancer drug discovery.Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model.Pharmacokinetics of Chlorin e₆-Cobalt Bis(Dicarbollide) Conjugate in Balb/c Mice with Engrafted Carcinoma.Development and validation of a physiology-based model for the prediction of pharmacokinetics/toxicokinetics in rabbits.
P2860
Physiologically based pharmacokinetic and pharmacodynamic modeling in cancer drug development: status, potential and gaps.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Physiologically based pharmaco ...... t: status, potential and gaps.
@en
type
label
Physiologically based pharmaco ...... t: status, potential and gaps.
@en
prefLabel
Physiologically based pharmaco ...... t: status, potential and gaps.
@en
P2860
P1476
Physiologically based pharmaco ...... t: status, potential and gaps.
@en
P2093
Michael Block
P2860
P304
P356
10.1517/17425255.2015.1037276
P407
P577
2015-05-01T00:00:00Z